Glucagon, GLP-1 co-infusion can reduce appetite

June 25, 2014
Glucagon, GLP-1 co-infusion can reduce appetite

(HealthDay)—Co-infusion of glucagon and glucagon-like peptide 1 (GLP-1) correlates with a reduction in appetite, and GLP-1 protects against glucagon-induced hyperglycemia in healthy volunteers, according to a study published online June 17 in Diabetes.

Jaimini Cegla, M.B.B.S., from Imperial College London in the United Kingdom, and colleagues conducted a double-blind, cross-over study involving 13 human volunteers to examine the effect of administration of a combination of glucagon and GLP-1. Sub-anorectic doses of each peptide alone, in combination, or placebo were infused into volunteers for 120 minutes. After 90 minutes, an ad libitum meal was provided, and was determined.

The researchers found that there was no significant reduction in with either glucagon or GLP-1 given individually. Co-infusion led to a significant 13 percent reduction in food intake. The addition of GLP-1 also offered protection against glucagon-induced hyperglycemia; co-infusion correlated with a 53kcal/day increase in energy expenditure.

"These observations support the concept of GLP-1 and glucagon dual agonism as a possible treatment for obesity and diabetes," the authors write.

Explore further: Importance of diabetes genetic variants unclear

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Importance of diabetes genetic variants unclear

April 4, 2012

(HealthDay) -- Genetic variants associated with type 2 diabetes that affect glucagon-like peptide 1 (GLP-1) are not associated with GLP-1 levels or GLP-1-induced insulin secretion in healthy individuals, according to a study ...

Artificial sweeteners produce no glucagon response

January 14, 2014

(HealthDay)—Artificial sweeteners do not produce any changes in glucose metabolism compared to a glass of water, according to a letter published in the December issue of Diabetes Care.

High-fat diet impairs satiation signaling in obese-prone

February 27, 2013

(HealthDay)—Feeding obese-prone rats a high-fat diet leads to impaired satiation signaling through glucagon-like peptide-1 (GLP-1), a gastrointestinal hormone that suppresses food intake and helps regulate energy balance, ...

Recommended for you

New theory on how insulin resistance, metabolic disease begin

September 26, 2016

Does eating too much sugar cause type 2 diabetes? The answer may not be simple, but a study published Sept. 26 in the Journal of Clinical Investigation adds to growing research linking excessive sugar consumption—specifically ...

Unique molecular atlas of pancreas produced

September 23, 2016

Researchers at Karolinska Institutet have managed to produce the first molecular map of the genes that are active in the various cells of the human pancreas. They have also revealed differences in genetic activity between ...

Can long naps cause diabetes?

September 14, 2016

A study presented at a scientific congress Thursday reported a link between long naps and a higher risk of diabetes, though it couldn't say if daytime sleeping was a symptom or a cause.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.